MaRS Innovation's President and CEO, Raphael Hofstein, has published an editorial outlining the challenges facing entrepreneurs seeking to bring new healthcare innovations to market for the National Post's Medical Devices…
Joel Liederman, MaRS Innovation’s vice-president of Business Development and Physical Sciences, is participating in a live chat on the Financial Post‘s website.
The chat will take place on June 28, 2012 at 2 pm.
Topic: Why Canada can’t do anything with its big ideas
When it comes to academic research and the development or discovery of new concepts or product models, there are few countries in the world that can hold a candle to Canada.
This week, MaRS Innovation (MI) announced a new partnership agreement with The Québec Consortium for Drug Discovery (CQDM), the Ontario Brain Institute (OBI) and Ontario Centres of Excellence (OCE) to launch the Québec/Ontario CQDM Funding Program.
The funding program will support collaborative life science research projects between the two provinces that seek to develop new tools for biopharmaceutical research.
The Financial Post and the National Post each ran a feature article June 18, 2012 concerning the United Kingdom’s efforts to attract Canadian-based technology start-ups seeking entrance into European markets.
Flybits, a Mars Innovation spin-off company based on the research of Ryerson University professor Hossein Rahnama, was among those profiled.
Ryerson University, one of MaRS Innovation’s 16 member institutions, has created the Digital Media Zone (DMZ) to give student entrepreneurs and researchers — or anyone connected with a great idea connected to their campus — the space they need to grow their ideas.
Dr. Hossein Rahnama, the DMZ’s research director and a Ryerson University professor, was interviewed this week by The Accelerator Gazette about Ryerson’s approach to accelerating and incubating technologies.
OtoSim Inc., a MaRS Innovation spin-off company, made its debut on Business News Network’s The Pitchon June 1, 2012.
Louis Hui, OtoSim’s business development manager, had 90 seconds to pitch OtoSim™ — an integrated educational system that dynamically and interactively teaches how to accurately diagnose ear diseases — to The Pitch’s panel of financiers and experts.
TORONTO (May 22, 2012) — Flybits CEO and Founder Hossein Rahnama was among the entrepreneurs of Ryerson University’s Digital Media Zone (DMZ) to meet the Prince of Wales and demonstrate his cloud-based and context-aware software solution.
Flybits Inc., a Mars Innovation spin-off company from Ryerson University where Rahanama is a professor and research director of the DMZ, has developed an innovative, context-aware software as a service framework called FARE (Flybits Activity Recognition Engine).
It allows mobile application developers to rapidly build intelligent mobile applications that address the needs of multiple vertical markets without excessive infrastructure requirements.
OtoSim Inc., a MaRS Innovation spin-off company, is taping an appearance on Business News Network’s The Pitch on May 22, 2012.
Louis Hui, OtoSim’s business development manager, will have 90 seconds to pitch OtoSim™ — an integrated educational system that dynamically and interactively teaches how to accurately diagnose ear diseases — to The Pitch’s panel of financiers and experts.
MaRS Innovation’s ScarX Therapeutics, a strategic partnership with The Hospital for Sick Children (SickKids) and NovoTek Therapeutics Inc. (NovoTek), was featured on the front page of the Globe and Mail on May 7, 2010.
Read the article on Globe and Mail.com (note that depending on when you’re accessing this page, the Globe‘s content may be subject to a pay wall).
TORONTO (January 30, 2012) – Xagenic Inc., a start-up company created by Dr. Shana Kelley, in partnership with MaRS Innovation, today reached a significant milestone by successfully completing series A financing totaling $10 million.
The financing comes from sources from the private and public sector including CTI Life Sciences Fund L.P., Qiagen N.V. and the Ontario Capital Growth Corporation through its Emerging Technologies Fund.
Schwartz Reisman Innovation Campus, West Tower
108 College Street, Suite 530
Toronto, ON M5G 0C6
info@tiap.ca